12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Bionomics preclinical data

In a mouse xenograft model of colorectal cancer, BNC101 significantly inhibited growth of re-implanted tumor cells following primary treatment vs. irinotecan-treated controls...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >